Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2025-06-30 00:00:00 ET · period of report 2025-06-26 · accession 0001213900-25-059655 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-30 | 2025-06-26+ | TARA | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -18.7K | 963.3K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-27 | G | D | 3,367 | $0.00 | 959,886 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-26 | G | D | 1,700 | $0.00 | 976,853 | D | — | — | |
| 3 | Common | Common Stock | 2025-06-26 | G | D | 3,400 | $0.00 | 973,453 | D | — | — | |
| 4 | Common | Common Stock | 2025-06-27 | G | D | 10,200 | $0.00 | 963,253 | D | — | — |